Systemic lupus erythematosus is specially a disease of young women in their child bearing age . It has been found that SLE disease activity can repair in pregnancy even though patient is in complete remission state before the pregnancy. Besides this, pregnancy complications are higher in SLE patients. Another important issue is the use of drugs to control SLE because some of these drugs are potentially terotogenic. Fetal outcome is also a challenging issue. Therefore, multidisciplinary approach has key role in the management of Lupus pregnancy.
Why SLE is important in pregnancy?
SLE is a disease condition, which is, not only hampers the normal life of a woman, but also can create a dangerous situation during pregnancy. Disease flare of SLE can occur during pregnancy. Pregnancy related complications are common with SLE. Fetal outcome is also poor. There is a increased risk of abortions (2-3 times), intrauterine growth retardation and stillbirth. Therefore, lupus pregnancy is labelled as 'high-risk' pregnancy.
SLE associated maternal diseases and complications:
SLE patients suffer from different kinds pregnancy related complication more frequently than non-SLE women do. Actually, there are two main problems; firstly increased pregnancy related complication due to SLE and secondly SLE disease flares due to pregnancy. 
Neonatal Lupus Syndrome:
Neonatal lupus syndrome is an unusual condition due to the passage of maternal antibodies (specially Anti-Ro/SS-A and Anti-La/SS-B) to unborn fetus. The main features are congenital heart block (CHB), transient cutaneous lupus lesions, Cytopenias, hepatic, and other systemic manifestations 9, 10 .
Antenatal care & Preconception counselling:
Same as normal non-SLE antenatal care; but more concentration should be given to identify early diseases flares; to search for SLE related pregnancy complications and regular monitoring of fetal conditions. Patients suffering from active disease, should be kept under special observation.
However, aims & objectives of normal non-SLE antenatal care are:
• To promote, protect and maintain the health of pregnant women
• To detect high risk cases and give them special attention
• To predict complications and prevent them
• To remove anxiety associated with pregnancy
• To reduce maternal and infant mortality and morbidity
• To teach elements of child care, nutrition, hygiene and sanitation
• To sensitize her regarding family planning
• To attend the under 5 children accompanying the mother
Preconception counselling & Planning for pregnancy:
Routine counselling of SLE patients with incomplete family should include emphasis on the need for planned pregnancy. The incidence of flare during pregnancy with conception while in remission is less than 10%. It is strongly recommended that the disease should be in clinical remission for at least 6 months before the patient plans for pregnancy. The best time for conception is after 6-12 months of remission with hydroxychloroquine but no cytotoxic drugs. At the onset of pregnancy, a complete assessment of disease activity and severity should be made. The spouse and other family members should be counselled 2 . Childbearing should not be contemplated in women with pulmonary hypertension and those with lupus nephritis with a baseline serum creatinine >250µmol/l 11 .
Evaluation at first visit: Initial evaluation should be based on thorough history taking and physical examination along with careful BP measurement. There are many controversies of using steroid in this group of patient to prevent flares as flare prophylaxis. Use of steroid increases the risk of fetal cleft palate, IUGR, PROM, DM, pre-eclamsia.
Treatment for Lupus flares:
Lupus flares should be treated with the appropriate steroid (usually prednisolone) dose. Azathioprine and cyclosporine can be used in pregnancy with active SLE.
Cytotoxic drugs such as cyclophosphamide should be avoided during first trimester except in rare circumstances such as pulmonary alveolar haemorrhage or class IV nephritis due to SLE 2 . These drugs have some side effects over pregnancy and fetus. Cyclophosphamide & Methotrexate are the most teratogenic among them and should be avoided in pregnancy. More safety data are needed for the use of mycophenolate mofetil. Some adverse effect of drugs on pregnancy has been descried in the following table-II.
Anti-phospholipid Antibody Syndrome (APS):
If antiphospholipid syndrome is present, there is greatly increased risk of thrombosis and foetal loss. Warfarin must be stopped as early as possible after conception (preferably the next day of her first mense is missed and pregnancy confirmed) and daily subcutaneous injections of low molecular weight heparin or low dose of heparin sodium along wih low dose aspirin must be continued until delivery. The heparin is omitted 12 hours before delivery or caesarean section whereas low dose aspirin may be continued. After post partum bleeding stops, usually within a week after delivery, warfarin is restarted. Corticosteroids are not recommended for APS alone because they increase maternal morbidity. In refractory cases, intravenous immunoglobulin (IVIG) can be tried 2 . Abortion and fetal loss is very much common in APS. Immunotherapy with IVIG that contains anti-idiotypes directed towards patients pathogenic antiphospholipid antibodies has been tried to prevent pregnancy loss in different centre 20 . 12 , premature rupture of membrane, hypertension 6 , preeclampsia, DM Azathioprine Found to be safe in therapeutic dose in different studies 13, 14 . However, some clinicians believe it causes bone marrow suppression both in mother and fetus. It has been found to be teratogenic in mice and rabbits.
Cyclosporine
Found to be safe in therapeutic dose in different studies 15 . The most important problem faced in the newborn whose mother is treated by cyclosporine is the severe intrauterine growth retardation, reported by Pickrell et al 16 .
Cyclophosphamide
Crosses the placenta and can cause fetal toxicity when administered to pregnant women. Abnormalities (missing fingers and/or toes, cardiac defects, hernias) have occurred in infants born to women treated with the drug during the pregnancy. Other complications like haemorrhagic cystitis, bone marrow suppression, infection etc may complicate pregnancy 17, 18 .
MTX
Potentially teratogenic. It causes neural tube defect 19 .
Anti-Ro or Anti-La antibodies positive women:
When incomplete heart block is detected in utero (detected by fetal doppler) , corticosteroids that cross the placenta (dexamethasone or betamethasone) need to be administered to the mother in order to decrease inflammation in the fetal heart and prevent progression to complete heart block 11, 21 . 
Neonatal care:
After delivery heart rate of the baby should be counted and also there should be a search for any cutaneous lesion.
Treatment of established congenital heart block (CHB) is difficult 23 . Therefore, it is better to prevent during pregnancy as mentioned earlier. Most of the time cutaneous lesion can be treated with topical steroids.
Puerperium:
During the postpartum period, the mother should be watched for infection and disease exacerbation; both require aggressive treatment, when detected. In Antiphospholipid antibody Syndrome, warfarin is restarted after bleeding stops.
Issues of Breast-feeding:
Majority of drugs are excreted in human milk in variable amounts. From neonatal perspective, maternal intake of prednisolone less than or up to 30 mg/day, warfarin, cyclosporine in standard doses and weekly chloroquine for malaria prophylaxis are considered safe. If the dose of prednisolone is greater than 30 mg/day, feeding should be avoided for 4 hours after ingestion of the morning dose of steroid. By this time the blood levels are quite low and very limited amounts are secreted into the milk. However, breastfeeding is contraindicated if mother is on cyclophosphamide, azathioprine, hydroxychloroquine for SLE.
Advice of contraception:
Barrier methods are the safest method for contraception. However, low dose estogen or progesterone only pills are relatively safe. High dose estrogen containing pill should be avoided. OCP should be avoided in antiphospholipid syndrome, other thromboembolic diseases, highly active disease, migraine, Raynaud's phenomenon. Use of intrauterine devices is controversial because it causes infections like endometritis, PID etc.
Conclusion:
SLE is a multisystem disease. Therefore, interdisciplinary approach is needed to treat the disease. Doctor, patient and her family should work together for planning of pregnancy and during pregnancy to overcome the complications.
